NO/LA Angel Network
VC Fund
New Orleans, United States
NO/LA Angel Network is a VC fund in New Orleans focused on Health Care and Biotechnology. The NO/LA Angel Network is a group of accredited investor.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries NO/LA Angel Network invests in
Stages NO/LA Angel Network invests in
Countries NO/LA Angel Network invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Mike Eckert
|
|||
Investment Focus
Industry
- Health Care 7 (47%)
- Biotechnology 5 (33%)
- Medical Device 3 (20%)
- Pharmaceutical 3 (20%)
- Software 2 (13%)
Stage
- Seed 3 (20%)
- Series A 3 (20%)
- Funding Round 2 (13%)
- Debt Financing 2 (13%)
- Convertible Note 2 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Mike Eckert
Founder and Chairman
|
Founder and Chairman | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NuvOx Therapeutics
|
NuvOx Pharma develops a platform for drugs that upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ibready). | $7M / Convertible Note / Sep 27, 2023 | |
Adranos Energetics
|
Adranos Energetics develops propellants, explosives, and other energetic materials for use in space and military platforms. It is currently developing a cost-effective solid rocket propellant that is more efficient, more powerful, and better for the environment than traditional solid rocket propellants. Its proprietary solid propellant, ALITEC,simultaneously increases rocket performance and eliminates the harmful hydrochloric acid (“HCl”) emissions of traditional, aluminum-based propellants. It provides a competitive advantage for its military users by extending missile range and enabling smaller, more affordable missiles. It will also enhance the capabilities of its space launch users by expanding payload capacity and lowering the cost of space access. | $20M / Series A / Apr 26, 2022 | |
Tympanogen
|
Tympanogen develops novel materials to improve treatment outcomes and decrease healthcare costs for otolaryngologists and their patients. Its flagship product, Perf-Fix, is the first gel patch for nonsurgical eardrum repair. | $1M / Debt Financing / Mar 09, 2022 | |
Ome
|
Ome develops smart, sustainable technology products that automate existing home appliances so families can spend more quality time together. Ome's flagship product is a patented Smart Knob that seamlessly replaces existing stove knobs so people can cook, control, and monitor their home appliances virtually, with ease. Ome Smart Knob'sfunctionality, among others, includes a built-in auto-off and safety-lock feature that delivers an enhanced level of security to some of the most hazardous places in the home. | $4.5M / Mar 04, 2022 | |
|
Ome
|
Ome develops smart, sustainable technology products that automate existing home appliances so families can spend more quality time together. Ome's flagship product is a patented Smart Knob that seamlessly replaces existing stove knobs so people can cook, control, and monitor their home appliances virtually, with ease. Ome Smart Knob'sfunctionality, among others, includes a built-in auto-off and safety-lock feature that delivers an enhanced level of security to some of the most hazardous places in the home. | $2.5M / Venture - Series Unknown / Mar 04, 2022 | |
CryptoStopper
|
Ransomware is rampant, a business fell victim to ransomware every 14 seconds in 2019. Existing technologies are not stopping it. Businesses and local governments across the globe are being shutdown by these attacks. On Dec 14th, 2019, the mayor of New Orleans declared a state of emergency after the city was infected by ransomware. Unfortunately,this is not an isolated incident. CryptoStopper™ is a ransomware protection SaaS business. Utilizing lure files deployed throughout a network, cyber criminal’s own techniques are turned against them to exterminate attacks before damage is done. According to the FBI, ransomware cripples another business in the US every 11 seconds. CryptoStopper™ is the only protection which will detect and stop active ransomware attacks on the network. | Venture - Series Unknown / Mar 01, 2022 | |
De Oro Devices
|
De Oro Devices is a device that re-establishing the connection between the brain and the body. Attach a NexStride to cane, walker, and walking poles that help to reduce the duration and frequency of freezing episodes. | $1.5M / Seed / Feb 17, 2022 | |
El Guapo Bitters
|
El Guapo Bitters is a producer and retailer of artisan syrups and bitters that offer a variety of cocktails to customers. Its syrups are made from gluten-free ingredients with no GMOs or corn syrup and it is extracted from the concentrated flavor of fresh fruits, vegetables, herbs, and spices. | $1.1M / Seed / Dec 03, 2021 | |
Xeno Biosciences
|
Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts. | $7.3M / Series A / Aug 08, 2021 | |
BioAesthetics
|
BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. The BioAesthetics’ initial product is a tissue-engineered nipple-areolar complex (NAC). This product will be provided to plastic and reconstructive surgeons as anoff-the-shelf ready, acellular, NAC graft. During the breast reconstruction phase, after a mastectomy, the surgeon would engraft the NAC graft in position onto the patient’s reconstructed breast. The patient’s body would then use this NAC graft as a building frame to regenerate their own NAC. This patent-pending product is currently in the pre-clinical phase. | $6.4M / Series A / Oct 05, 2020 | |
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does NO/LA Angel Network invest in?
NO/LA Angel Network invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed and Series A stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact NO/LA Angel Network?
Public channels for NO/LA Angel Network include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NO/LA Angel Network?
The team at NO/LA Angel Network includes Mike Eckert (Founder and Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
